PMID- 12652570 OWN - NLM STAT- MEDLINE DCOM- 20030731 LR - 20061115 IS - 0173-0835 (Print) IS - 0173-0835 (Linking) VI - 24 IP - 1-2 DP - 2003 Jan TI - Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis. PG - 26-33 AB - For facilitated genotypic analysis of multiple endocrine neoplasia type 1 (MEN1), a familial syndrome associated with tumors of the parathyroid and neuroendocrine tissues, we developed two screening methods, heteroduplex mutation assay (HMA) and mutation detection gel analysis (MDGA), both based on electrophoretic discrimination of polymerase chain reaction (PCR) products, to detect the mutations. Forty-three genomic DNA samples were used for the evaluation of these techniques. The whole coding region of MEN1 was PCR-amplified with fluorescent primers and then denatured/renatured before electrophoresis on an automated sequencer. 100% of the mutations were detected, subsequently confirmed and identified by sequencing. "Negative" samples were used to evaluate the specificity and reproducibility of the two techniques. The combination of the two methods allows high throughput cost-effective mutation screening which is less laborious than systematic sequencing of the whole coding region of MEN1. Together, these methods provide an efficient screen for MEN1 mutations. FAU - Crepin, Michel AU - Crepin M AD - Secteur Oncologie Moleculaire Huriez-USN, Laboratoire de Biochimie et Biologie Moleculaire, CHRU, Lille, France. FAU - Escande, Fabienne AU - Escande F FAU - Pigny, Pascal AU - Pigny P FAU - Buisine, Marie-P AU - Buisine MP FAU - Calender, Alain AU - Calender A FAU - Porchet, Nicole AU - Porchet N FAU - Odou, Marie-Francoise AU - Odou MF CN - Groupe d'Etude des Neoplasies Endocriniennes Multiples, Lyon LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Electrophoresis JT - Electrophoresis JID - 8204476 RN - 0 (DNA Primers) RN - 0 (MEN1 protein, human) RN - 0 (Neoplasm Proteins) RN - 0 (Proto-Oncogene Proteins) SB - IM MH - Base Sequence MH - DNA Mutational Analysis/*methods/statistics & numerical data MH - DNA Primers/genetics MH - Electrophoresis, Agar Gel MH - *Genes, Tumor Suppressor MH - Heteroduplex Analysis/*methods/statistics & numerical data MH - Humans MH - Multiple Endocrine Neoplasia Type 1/genetics MH - Mutation MH - Neoplasm Proteins/*genetics MH - Polymerase Chain Reaction MH - *Polymorphism, Single-Stranded Conformational MH - *Proto-Oncogene Proteins MH - Reproducibility of Results MH - Sensitivity and Specificity EDAT- 2003/03/26 04:00 MHDA- 2003/08/02 05:00 CRDT- 2003/03/26 04:00 PHST- 2003/03/26 04:00 [pubmed] PHST- 2003/08/02 05:00 [medline] PHST- 2003/03/26 04:00 [entrez] AID - 10.1002/elps.200390023 [doi] PST - ppublish SO - Electrophoresis. 2003 Jan;24(1-2):26-33. doi: 10.1002/elps.200390023.